CA 19-9 (pancreatic tumor marker)
This test is done to measure CA 19-9, a protein that may be elevated in pancreatic cancer and some other gastrointestinal cancers such as bile duct or gastric cancer. It is primarily used to monitor treatment response, detect disease progression, and support clinical evaluation rather than for routine screening.